{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:19:10Z","timestamp":1783531150654,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11655-024-3667-y","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T16:01:57Z","timestamp":1726934517000},"page":"215-227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Qishen Granules Modulate Metabolism Flexibility Against Myocardial Infarction via HIF-1 \u03b1-Dependent Mechanisms in Rats"],"prefix":"10.1007","volume":"31","author":[{"given":"Xiao-qian","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-wen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,21]]},"reference":[{"key":"3667_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation 2021;143:e254\u2013e7432.","journal-title":"Circulation"},{"key":"3667_CR2","first-page":"891","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;18:891\u2013975.","journal-title":"Eur Heart J"},{"key":"3667_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol 2018;15:457\u2013470.","journal-title":"Nat Rev Cardiol"},{"key":"3667_CR4","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10741-017-9623-6","volume":"22","author":"A Gupta","year":"2017","unstructured":"Gupta A, Houston B. A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition. Heart Fail Rev 2017;22:825\u2013842.","journal-title":"Heart Fail Rev"},{"key":"3667_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41392-023-01499-0","volume":"8","author":"N Jia","year":"2023","unstructured":"Jia N, Gao Y, Li M, Liang Y, Li Y, Lin Y, et al. Metabolic reprogramming of proinflammatory macrophages by target delivered roburic acid effectively ameliorates rheumatoid arthritis symptoms. Signal Transduct Target Ther 2023;8:280.","journal-title":"Signal Transduct Target Ther"},{"key":"3667_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","volume":"5","author":"GN Masoud","year":"2015","unstructured":"Masoud GN, Li W. HIF-1 \u03b1 pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B 2015;5:378\u2013389.","journal-title":"Acta Pharm Sin B"},{"key":"3667_CR7","first-page":"e2303904","volume-title":"Adv Sci (Weinh)","author":"J Wang","year":"2023","unstructured":"Wang J, Yang C, Xu H, Fan X, Jia L, Du Y, et al. The interplay between HIF-1 \u03b1 and EZH2 in lung cancer and dual-targeted drug therapy. Adv Sci (Weinh) 2023;e2303904."},{"key":"3667_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s13063-017-2193-z","volume":"18","author":"J Wang","year":"2017","unstructured":"Wang J, Shi J, Wei J, Wang J, Gao K, Li X, et al. Safety and efficacy of Qishen Granules in patients with chronic heart failure: study protocol for a randomized controlled trial. Trials 2017;18:468.","journal-title":"Trials"},{"key":"3667_CR9","doi-asserted-by":"publisher","first-page":"1642575","DOI":"10.1155\/2019\/1642575","volume":"2019","author":"J Zhang","year":"2019","unstructured":"Zhang J, Liu J, Gao S, Lin W, Gao P, Gao K, et al. Antiapoptosis and antifibrosis effects of Qishen Granules on heart failure rats via Hippo pathway. Biomed Res Int 2019;2019:1642575.","journal-title":"Biomed Res Int"},{"key":"3667_CR10","doi-asserted-by":"publisher","first-page":"850187","DOI":"10.3389\/fphar.2022.850187","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Li X, Chen X, Sun X, Liu X, Wang G, et al. Qishen Granule (QSG) inhibits monocytes released from the spleen and protect myocardial function via the TLR4-MyD88-NF- \u03ba B p65 pathway in heart failure mice. Front Pharmacol 2022;13:850187.","journal-title":"Front Pharmacol"},{"key":"3667_CR11","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.2147\/JIR.S373962","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Sun X, Liu X, Li J, Li X, Wang G, et al. P2X7R-NEK7-NLRP3 inflammasome activation: a novel therapeutic pathway of Qishen Granule in the treatment of acute myocardial ischemia. J Inflamm Res 2022;15:5309\u20135326.","journal-title":"J Inflamm Res"},{"key":"3667_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/jamacardio.2016.4828","volume":"2","author":"MB Elam","year":"2017","unstructured":"Elam MB, Ginsberg HN, Lovato LC, Corson M, Largay J, Leiter LA, et al. Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. JAMA Cardiol 2017;2:370\u2013380.","journal-title":"JAMA Cardiol"},{"key":"3667_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ijcard.2019.05.063","volume":"293","author":"M Marzilli","year":"2019","unstructured":"Marzilli M, Vinereanu D, Lopaschuk G, Chen Y, Dalal JJ, Danchin N, et al. Trimetazidine in cardiovascular medicine. Int J Cardiol 2019;293:39\u201344.","journal-title":"Int J Cardiol"},{"key":"3667_CR14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res 2021;128:1487\u20131513.","journal-title":"Circ Res"},{"key":"3667_CR15","doi-asserted-by":"publisher","first-page":"e137557","DOI":"10.1172\/JCI137557","volume":"131","author":"AK Knutson","year":"2021","unstructured":"Knutson AK, Williams AL, Boisvert WA, Shohet RV. HIF in the heart: development, metabolism, ischemia, and atherosclerosis. J Clin Invest 2021;131:e137557.","journal-title":"J Clin Invest"},{"key":"3667_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001;292:464\u2013468.","journal-title":"Science"},{"key":"3667_CR17","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468\u2013472.","journal-title":"Science"},{"key":"3667_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010;40:294\u2013309.","journal-title":"Mol Cell"},{"key":"3667_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijcard.2017.12.080","volume":"257","author":"C Brenner","year":"2018","unstructured":"Brenner C. In depth understanding of adverse ventricular remodeling after acute myocardial infarction. Int J Cardiol 2018;257:34.","journal-title":"Int J Cardiol"},{"key":"3667_CR20","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1161\/CIRCULATIONAHA.117.028274","volume":"136","author":"AA Gibb","year":"2017","unstructured":"Gibb AA, Epstein PN, Uchida S, Zheng Y, McNally LA, Obal D, et al. Exercise-induced changes in glucose metabolism promote physiological cardiac growth. Circulation 2017;136:2144\u20132157.","journal-title":"Circulation"},{"key":"3667_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1007\/s11427-020-1792-5","volume":"64","author":"Q Wan","year":"2021","unstructured":"Wan Q, Kong D, Liu Q, Guo S, Wang C, Zhao Y, et al. Congestive heart failure in COX2 deficient rats. Sci China Life Sci 2021;64:1068\u20131076.","journal-title":"Sci China Life Sci"},{"key":"3667_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamacardio.2018.4847","volume":"4","author":"CJ Coats","year":"2019","unstructured":"Coats CJ, Pavlou M, Watkinson OT, Protonotarios A, Moss L, Hyland R, et al. Effect of trimetazidine dihydrochloride therapy on exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy: a randomized clinical trial. JAMA Cardiol 2019;4:230\u2013235.","journal-title":"JAMA Cardiol"},{"key":"3667_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","volume":"68","author":"C Dreyer","year":"1992","unstructured":"Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992;68:879\u2013887.","journal-title":"Cell"},{"key":"3667_CR24","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.3390\/ijms19113464","volume":"19","author":"Z Khuchua","year":"2018","unstructured":"Khuchua Z, Glukhov AI, Strauss AW, Javadov S. Elucidating the beneficial role of PPAR agonists in cardiac diseases. Int J Mol Sci 2018;19:3464.","journal-title":"Int J Mol Sci"},{"key":"3667_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol 2021;18:809\u2013823.","journal-title":"Nat Rev Cardiol"},{"key":"3667_CR26","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1093\/eurheartj\/ehab431","volume":"42","author":"L Da Dalt","year":"2021","unstructured":"Da Dalt L, Castiglioni L, Baragetti A, Audano M, Svecla M, Bonacina F, et al. PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction. Eur Heart J 2021;42:3078\u20133090.","journal-title":"Eur Heart J"},{"key":"3667_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.molcel.2020.05.007","volume":"79","author":"A He","year":"2020","unstructured":"He A, Chen X, Tan M, Chen Y, Lu D, Zhang X, et al. Acetyl-CoA Derived from hepatic peroxisomal \u03b2 -oxidation inhibits autophagy and promotes steatosis via mTORC1 activation. Mol Cell 2020;79:30\u201342.e4.","journal-title":"Mol Cell"},{"key":"3667_CR28","doi-asserted-by":"publisher","first-page":"H958","DOI":"10.1152\/ajpheart.00279.2018","volume":"315","author":"WM Torres","year":"2018","unstructured":"Torres WM, Jacobs J, Doviak H, Barlow SC, Zile MR, Shazly T, et al. Regional and temporal changes in left ventricular strain and stiffness in a porcine model of myocardial infarction. Am J Physiol Heart Circ Physiol 2018;315:H958\u2013H967.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3667_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/CIRCULATIONAHA.118.038944","volume":"140","author":"K van Duijvenboden","year":"2019","unstructured":"van Duijvenboden K, de Bakker DEM, Man JCK, Janssen R, G\u03bcnthel M, Hill MC, et al. Conserved NPPB+ border zone switches from MEF2- to AP-1-driven gene program. Circulation 2019;140:864\u2013879.","journal-title":"Circulation"},{"key":"3667_CR30","doi-asserted-by":"publisher","first-page":"e24036","DOI":"10.1371\/journal.pone.0024036","volume":"6","author":"L Xu","year":"2011","unstructured":"Xu L, Deng Y, Feng L, Li D, Chen X, Ma C, et al. Cardioprotection of salvianolic acid B through inhibition of apoptosis network. PLoS One 2011;6:e24036.","journal-title":"PLoS One"},{"key":"3667_CR31","first-page":"731","volume":"21","author":"HL Kong","year":"2018","unstructured":"Kong HL, Hou AJ, Liu NN, Chen BH, Dai SN, Huang HT. The effects of ginsenoside Rb1 on fatty acid \u03b2 -oxidation, mediated by AMPK, in the failing heart. Iran J Basic Med Sci 2018;21:731\u2013737.","journal-title":"Iran J Basic Med Sci"},{"key":"3667_CR32","doi-asserted-by":"publisher","first-page":"109487","DOI":"10.1016\/j.biopha.2019.109487","volume":"120","author":"X Chen","year":"2019","unstructured":"Chen X, Wang Q, Shao M, Ma L, Guo D, Wu Y, et al. Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPAR\u03b1 pathway. Biomed Pharmacother 2019;120:109487.","journal-title":"Biomed Pharmacother"},{"key":"3667_CR33","doi-asserted-by":"publisher","first-page":"BSR20171036","DOI":"10.1042\/BSR20171036","volume":"38","author":"B Tang","year":"2018","unstructured":"Tang B, Zhang JG, Tan HY, Wei XQ. Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure. Biosci Rep 2018;38:BSR20171036.","journal-title":"Biosci Rep"},{"key":"3667_CR34","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCRESAHA.119.315268","volume":"124","author":"JT Willerson","year":"2019","unstructured":"Willerson JT. The medical and device-related treatment of heart failure. Circ Res 2019;124:1519.","journal-title":"Circ Res"},{"key":"3667_CR35","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","volume":"356","author":"S Neubauer","year":"2007","unstructured":"Neubauer S. The failing heart\u2014an engine out of fuel. N Engl J Med 2007;356:1140\u20131151.","journal-title":"N Engl J Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-024-3667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-024-3667-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-024-3667-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T09:57:08Z","timestamp":1740477428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-024-3667-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,21]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3667"],"URL":"https:\/\/doi.org\/10.1007\/s11655-024-3667-y","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,21]]},"assertion":[{"value":"20 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}